Posted on 6/16/20

Fusion Pharmaceuticals IPO: Say No To One-Product Biotech IPOs

SummaryFusion Pharmaceuticals has filed for a $100 million IPO, which it intends to use to further developments into its new drug.Its main drug, FPI-1434, has immense . . .